The Genetics of Autism
Approximately 10% of the cases of autism are probably in some way genetically
derived. In other words they have taken
place due to the genes of the parents and, if neither of the parents are ASD
affected, it would be reasonable to expect that only 1 in 4 of further children
would have the conditions. However,
this single gene idea is simply not reasonable in that even if one of identical
twins (i.e. with all their genes the same; monozygotic) there is only a 93%
that the other will be. The statistics
for non-identical twins shows that they also have a decent chance of having
autism if one has it (but this data is wide with 0% to 40% chances have been
reported). The excess of ASD in boys is
quite clear in that approximately 3-4 cases are in boys rather than girls. This led a lot of the researchers to look at
the X-
chromosome
(of which there is only one in boys). These figures are simply inadequate for
denying that an environmental factor being involved as well: for instance the
increase that has taken place (see figure from US cases) cannot be explained
genetically. Also it has become clear
that twins and second children often do not have similar psychological symptoms
of ASD to each other. The work has been
well reviewed but is still showing further genetics that
may be involved.
Some genetic changes seem to be reliably associated with ASD but some do not in that some of the genetic changes sometimes have it and in other cases this does not happen. This is known as non-specific association. The fact that some genetic modifications are closely associated with a likelihood of ASD has led some researchers to feel that all cases must have some kind of genetic aspect to them. However, the apparent increase in cases that we seem to have seen of autism over the last 15 years does suggest that either the genes are becoming modified faster than they were before or, because the ASD people uncommonly have many children, a specifically large gene is specifically involved. An example of this would be to look at cystic fibrosis, where again there is a range of different clinical severities, and about one person in 23 is thought to carry a modified specific gene. In CF it is because the gene is so large that it is commonly likely to be changed. It also should be noted that the autism of some genetically associated cases are not psychologically the same as seen in other groups and as such some researchers wonder whether the genetic aspects are a misleading source of information.
Some elements and genes associated
with ASD:
· Advanced glycation end product changes
· Many individual genetic modifications, particularly of chromosome 6 (these are not reviewed here but see Muhle et al below). See non-specific range
· Neurofibromatosis type 1
· Neuroligin and Neurexin (X-linked)
Excellent Scientific Reviews:
This can be looked on in a way
as autism being associated with known genetic conditions (e.g. Alpert’s
syndrome) or with specific genes and these separate directions gradually meet
up (but not yet!)
Muhle
R, Trentacoste
SV, Rapin
I. The genetics of autism. Pediatrics. 2004
May;113(5):e472-86.. Major Review in 2004. They make it clear that there is no
specific gene that will produce the disease reliably but they explain which
specific parts are aimed at being involved.
They also are not that impressed that all the ASDs are in fact the same
condition (e.g. fragile X ASD is in fact often associated with other changes in
the body like hyperorchidism). They explain that the association between
monozygotic twins is not perfect (93%) and familial changes are difficult to be
sure of in that they depend on the way in which the diagnosis is made. The reason for this is that there is almost
certainly an environmental factor as well on which the genetic factor depends
to produce the ASD. There are many genetic syndromes associated with autism but
only a limited range appear to have useful that may indicate more about autism
itself. The full list of syndromes is here but more useful ones are discussed
to a greater extent further on: Angelman syndrome, Prader-Willi syndrome, 15q11-q13
duplication, fragile X syndrome, fragile X premutation, deletion of chromosome
2q, XYY syndrome, Smith-Lemli-Opitz syndrome, Apert syndrome, mutations in the
ARX gene, De Lange syndrome, Smith-Magenis syndrome, Williams syndrome, Rett
syndrome, Noonan syndrome, Down syndrome, velo-cardio-facial syndrome, myotonic
dystrophy, Steinert disease, tuberous sclerosis, Duchenne's disease, Timothy syndrome,
10p terminal deletion, Cowden syndrome, 45,X/46,XY mosaicism, Myhre syndrome,
Sotos syndrome, Cohen syndrome, Goldenhar syndrome, Joubert syndrome,
Lujan-Fryns syndrome, Moebius syndrome, hypomelanosis of Ito, neurofibromatosis
type 1, CHARGE syndrome and HEADD syndrome.
(see this article to look up a lot of the specific syndromes that may,
or may not have autism as part of them).
Szatmari P, Paterson AD et al . Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet. 2007 Mar;39(3):319-28. Epub 2007 Feb 18. This has a very large number of authors and is particularly interested to implicate chromosome 11p12-p13 and neurexins.
Grice
DE, Buxbaum JD. The genetics of
autism spectrum disorders.
Neuromolecular Med. 2006;8(4):451-60. Review (this article looks very much into the
genetic DNA direction rather than the syndrome association of autism.
Burmeister
M, McInnis MG, Zöllner S. Psychiatric
genetics: progress amid controversy.
Nat Rev Genet. 2008 Jul;9(7):527-40. Review.
Mendelsohn
NJ, Schaefer GB. Genetic evaluation
of autism. Semin Pediatr Neurol. 2008
Mar;15(1):27-31.
Review. (They go into the ways in which this is being investigated)
Return to Home Page and Top of Page
Non-specific
associations of a range of genetic
conditions:
Warren
RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, DeWitt CW, McCullough M.
Possible association of the extended MHC haplotype B44-SC30-DR4 with autism.
Immunogenetics. 1992;36(4):203-7.
Warren
RP, Yonk J, Burger RW, Odell D, Warren WL. DR-positive T cells in autism:
association with decreased plasma levels of the complement C4B protein
Neuropsychobiology. 1995;31(2):53-7.
Nishimura
Y, Martin CL, Vazquez-Lopez A, Spence SJ, Alvarez-Retuerto AI, Sigman M, Steindler
C, Pellegrini S, Schanen NC, Warren ST, Geschwind DH. Genome-wide
expression profiling of lymphoblastoid cell lines distinguishes different forms
of autism and reveals shared pathways. Hum Mol Genet. 2007 Jul 15;16(14):1682-98.
Epub 2007 May 21
Nishimura K, Nakamura K,
Anitha A, et al. Genetic analyses of
the brain-derived neurotrophic factor (BDNF) gene in autism. Biochem Biophys
Res Commun. 2007 Apr 27;356(1):200-6. (A protein that is associated with the serotonergic
system. They found that alterations in haplotypes were associated with autism)
Nakamine
A, Ouchanov L, Jiménez P, Manghi ER, Esquivel M, Monge S, Fallas M, Burton BK,
Szomju B, Elsea SH, Marshall CR, Scherer SW, McInnes LA. Duplication of
17(p11.2p11.2) in a male child with autism and severe language delay. Am J Med
Genet A. 2007
Hu
VW, Frank BC, Heine S, Lee NH, Quackenbush J. Gene expression profiling of
lymphoblastoid cell lines from monozygotic twins discordant in severity of
autism reveals differential regulation of neurologically relevant genes. BMC
Genomics. 2006 May 18;7:118.
(suggesting how the environmental factor is involved)
Junaid
MA, Kowal D, Barua M, Pullarkat PS, Sklower Brooks S, Pullarkat RK. Proteomic studies identified a single
nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A. 2004 Nov 15;131(1):11-7
James
SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K,
Boris M, Bradstreet JJ, Baker SM, Gaylor DW. Metabolic endophenotype and
related genotypes are associated with oxidative stress in children with autism.
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141(8):947-56. (the interesting thing
about this one is that they are suggesting that the oxidative stress problem
comes first and, as a result the autism is seen…as opposed to the damage coming
first and the oxidative stress appearing later)
Sahoo
T, Shaw CA, Young AS, Whitehouse NL, Schroer RJ, Stevenson RE, Beaudet AL.
Array-based comparative genomic mutation in analysis of recurrent chromosome
15q rearrangements. Am J Med Genet A. 2005 Dec 1;139(2):106-13. (15q is associated with
GABA receptors. New (non-published)
data is coming out from the Boston area in which a fragment of chromosome 16 is
missing or altered in autistic children.
Molloy
CA, Keddache M, Martin LJ. Evidence for
linkage on 21q and 7q in a subset of autism characterized by developmental
regression. Mol Psychiatry. 2005 Aug;10(8):741-6.
Nishimura
K, Nakamura K, Anitha A, Yamada K, Tsujii M, Iwayama Y, Hattori E, Toyota T,
Takei N, Miyachi T, Iwata Y, Suzuki K, Matsuzaki H, Kawai M, Sekine Y, Tsuchiya
K, Sugihara G, Suda S, Ouchi Y, Sugiyama T, Yoshikawa T, Mori N. Genetic analyses of the brain-derived neurotrophic
factor (BDNF) gene in autism. Biochem Biophys Res Commun. 2007 Apr 27;356(1):200-6.
Epub 2007
Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, Nanba E, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N, Sasaki T. Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study. Brain Dev. 2007 Sep;29(8):510-3. Epub 2007 Mar 21. (To elucidate the genetic background of autism, we analyzed the relationship between three single nucleotide polymorphisms (SNPs) of the Tachykinin 1 gene (TAC1) and autism, because TAC1 is located in the candidate region for autism and produces substance P and neurokinins. These products modulate glutamatergic excitatory synaptic transmission and are also involved in inflammation. They found that Thus, the TAC1 locus is not likely to play a major role in the development of autism.)
Toyoda T, Nakamura K, Yamada K, Thanseem I, Anitha A,
Suda S, Tsujii M, Iwayama Y, Hattori E, Toyota T, Miyachi T, Iwata Y, Suzuki K,
Matsuzaki H, Kawai M, Sekine Y, Tsuchiya K, Sugihara G, Ouchi Y, Sugiyama T,
Takei N, Yoshikawa T, Mori N. SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal
haplotypic association of EGF with autism. Biochem Biophys Res Commun. 2007 Sep
7;360(4):715-20.
Epub 2007 Jun 18. (Epidermal growth
factor (EGF) is detected in several regions of the developing and adult brain,
where, it enhances the differentiation, maturation, and survival of a variety
of neurons. Transforming growth factor-beta (TGFbeta) isoforms play an
important role in neuronal survival, and the hepatocyte growth factor (HGF) has
been shown to exhibit neurotrophic activity.
They could find no oddities for TGF or HGF genetically but they suggest
EGF changes may be involved)
Anitha
A, Nakamura K, Yamada K, Suda S, Thanseem I, Tsujii M, Iwayama Y, Hattori E,
Toyota T, Miyachi T, Iwata Y, Suzuki K, Matsuzaki H, Kawai M, Sekine Y,
Tsuchiya K, Sugihara GI, Ouchi Y, Sugiyama T, Koizumi K, Higashida H, Takei N,
Yoshikawa T, Mori N. Genetic analyses of Roundabout (ROBO) axon guidance
receptors in autism. Am J Med Genet B Neuropsychiatr Genet. 2008 Feb 12.
(Abnormalities of ROBO may lead to autism either by interfering with
serotonergic system, or by disrupting neurodevelopment. To the best of our
knowledge, this is the first report relating ROBO with autism. This is more of a suggestion than a finding
of an answer)
Marui
T, Koishi S, Funatogawa I, Yamamoto K, Matsumoto H, Hashimoto O, Ishijima M,
Nanba E, Nishida H, Sugiyama T, Kasai K, Watanabe K, Kano Y, Kato N, Sasaki T. No association between the neuronal pentraxin II gene
polymorphism and autism. Prog Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):940-3.
Ramoz
N, Cai G, Reichert JG, Silverman JM, Buxbaum JD. An analysis of candidate autism loci on chromosome
2q24-q33: Evidence for association to the STK39 gene. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 17. (a quite wide statistical association )
Autism
Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W,
Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C,
Bryson SE, Jones MB, Marshall CR, Scherer SW, Vieland VJ, Bartlett C, Mangin
LV, Goedken R, Segre A, Pericak-Vance MA, Cuccaro ML, Gilbert JR, Wright HH,
Abramson RK, Betancur C, Bourgeron T, Gillberg C, Leboyer M, Buxbaum JD, Davis
KL, Hollander E, Silverman JM, Hallmayer J, Lotspeich L, Sutcliffe JS, Haines
JL, Folstein SE, Piven J, Wassink TH, Sheffield V, Geschwind DH, Bucan M, Brown
WT, Cantor RM, Constantino JN, Gilliam TC, Herbert M, Lajonchere C, Ledbetter
DH, Lese-Martin C, Miller J, Nelson S, Samango-Sprouse CA, Spence S, State M,
Tanzi RE, Coon H, Dawson G, Devlin B, Estes A, Flodman P, Klei L, McMahon WM,
Minshew N, Munson J, Korvatska E, Rodier PM, Schellenberg GD, Smith M, Spence
MA, Stodgell C, Tepper PG, Wijsman EM, Yu CE, Rogé B, Mantoulan C, Wittemeyer
K, Poustka A, Felder B, Klauck SM, Schuster C, Poustka F, Bölte S,
Feineis-Matthews S, Herbrecht E, Schmötzer G, Tsiantis J, Papanikolaou K,
Maestrini E, Bacchelli E, Blasi F, Carone S, Toma C, Van Engeland H, de Jonge
M, Kemner C, Koop F, Langemeijer M, Hijmans C, Staal WG, Baird G, Bolton PF,
Rutter ML, Weisblatt E, Green J, Aldred C, Wilkinson JA, Pickles A, Le Couteur
A, Berney T, McConachie H, Bailey AJ, Francis K, Honeyman G, Hutchinson A, Parr
JR, Wallace S, Monaco AP, Barnby G, Kobayashi K, Lamb JA, Sousa I, Sykes N,
Cook EH, Guter SJ, Leventhal BL, Salt J, Lord C, Corsello C, Hus V, Weeks DE,
Volkmar F, Tauber M, Fombonne E, Shih A, Meyer KJ. Mapping autism risk loci using genetic linkage and
chromosomal rearrangements. Nat Genet.
2007 Mar;39(3):319-28. Epub 2007 Feb 18. (they attempt to show an increase
in certain gene loci (or decrease) being associated with autism. A very difficult process as few other elements
of data are used to assess the patients)
Buxbaum
JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J, Råstam M, Silverman JM,
Hollander E, Gillberg C, Leboyer M, Betancur C. Mutation analysis of the NSD1 gene in patients with
autism spectrum disorders and macrocephaly. BMC Med Genet. 2007 Nov 14;8:68.
Buxbaum
JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsäter H, Rastam
M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur
C. Mutation screening of the PTEN
gene in patients with autism spectrum disorders and macrocephaly.
Am J Med Genet B
Neuropsychiatr Genet. 2007 Jun 5;144B(4):484-91
Sakurai
T, Ramoz N, Reichert JG, Corwin TE, Kryzak L, Smith CJ, Silverman JM, Hollander
E, Buxbaum JD. Association
analysis of the NrCAM gene in autism and in subsets of families with severe
obsessive-compulsive or self-stimulatory behaviors.
Psychiatr Genet. 2006 Dec;16(6):251-7.
Ramoz
N, Cai G, Reichert JG, Corwin TE, Kryzak LA, Smith CJ, Silverman JM, Hollander
E, Buxbaum JD. Family-based
association study of TPH1 and TPH2 polymorphisms in autism. Am J Med Genet B
Neuropsychiatr Genet. 2006 Dec 5;141B(8):861-7.
Ramoz N, Reichert JG, Corwin TE, Smith CJ, Silverman JM, Hollander E, Buxbaum JD. Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry. 2006 Jul 15;60(2):186-91. Epub 2006 Apr 17. see other site on serotonin site
Richler E, Reichert JG, Buxbaum JD, McInnes LA. Autism and ultraconserved non-coding sequence on
chromosome 7q. Psychiatr Genet. 2006 Feb;16(1):19-23. (results show that these
sequences are unlikely to harbour major autism susceptibility alleles)
Faham M, Zheng J, Moorhead M, Fakhrai-Rad H,
Namsaraev E, Wong K, Wang Z, Chow SG, Lee L, Suyenaga K, Reichert J, Boudreau
A, Eberle J, Bruckner C, Jain M, Karlin-Neumann G, Jones HB, Willis TD, Buxbaum
JD, Davis RW. Multiplexed
variation scanning for 1,000 amplicons in hundreds of patients using mismatch
repair detection (MRD) on tag arrays. Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14717-22.
Epub 2005 Oct 3. (this was showing how the method that they were using would
show a difference between specific different amplicons in an autistic patient
compared with a control).
Buxbaum
JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N, Reichert JG. Linkage analysis for autism in a subset families with
obsessive-compulsive behaviors: evidence for an autism susceptibility gene on
chromosome 1 and further support for susceptibility genes on chromosome 6 and
19. Mol Psychiatry. 2004 Feb;9(2):144-50. (suggest that there is an autism susceptibility gene
on chromosome 1 and provide further support for the presence of autism
susceptibility genes on chromosomes 6 and 19)
Weiss
LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, Reichert J, Buxbaum
JD, Meisler MH. Sodium channels
SCN1A, SCN2A and SCN3A in familial autism.
Mol Psychiatry. 2003 Feb;8(2):186-94. (The variant R1902C in SCN2A is located in the
calmodulin binding site and was found to reduce binding affinity for
calcium-bound calmodulin. R542Q in SCN1A was observed in one autism family…just
a bit lacking in statistics for autism and further work needs to be carried
out)
Buxbaum
JD, Silverman JM, Smith CJ, Kilifarski M, Reichert J, Hollander E, Lawlor BA,
Fitzgerald M, Greenberg DA, Davis KL. Evidence for a susceptibility gene for autism on chromosome 2 and for
genetic heterogeneity. Am J Hum Genet.
2001 Jun;68(6):1514-20. Epub 2001 May 14. Erratum in: Am J Hum Genet 2001
Aug;69(2):470.
Bolton PF, Veltman MW, Weisblatt E, Holmes JR, Thomas
NS, Youings SA, Thompson RJ, Roberts SE, Dennis NR, Browne CE, Goodson S, Moore
V, Brown J. Chromosome 15q11-13
abnormalities and other medical conditions in individuals with autism spectrum
disorders.
Psychiatr Genet. 2004 Sep;14(3):131-7.
Bacchelli
E, Blasi F, Biondolillo M, Lamb JA, Bonora E, Barnby G, Parr J, Beyer KS, Klauck
SM, Poustka A, Bailey AJ, Monaco AP, Maestrini E; International Molecular
Genetic Study of Autism Consortium (IMGSAC). Screening of nine candidate genes for autism on
chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol
Psychiatry. 2003 Nov;8(11):916-24.
Newbury
DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G, Jannoun L, Slonims V, Stott
CM, Merricks MJ, Bolton PF, Bailey AJ, Monaco AP; International Molecular
Genetic Study of Autism Consortium. FOXP2 is not a major susceptibility gene for autism or specific language
impairment. Am J Hum Genet. 2002 May;70(5):1318-27. Epub 2002 Mar 13.
International Molecular Genetic Study of Autism
Consortium (IMGSAC). A genomewide screen
for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J
Hum Genet. 2001 Sep;69(3):570-81. Epub 2001 Jul 30.
(they have got the money, the time, the laboratory, the methods but it
is exceptionally difficult to nail down a specific gene that is the cause. These were some of the first attempts that
they had)
International
Molecular Genetic Study of Autism Consortium (IMGSAC). Further characterization of the autism susceptibility
locus AUTS1 on chromosome 7q. Hum Mol Genet. 2001 Apr 15;10(9):973-82.
Rabionet R, Jaworski JM, Ashley-Koch AE, Martin ER,
Sutcliffe JS, Haines JL, Delong GR, Abramson RK, Wright HH, Cuccaro ML, Gilbert
JR, Pericak-Vance MA. Analysis of the
autism chromosome 2 linkage region: GAD1 and other candidate genes. Neurosci
Lett. 2004 Dec 6;372(3):209-14. (they found no association)
Sweeten TL, Odell DW, Odell JD, Torres AR. C4B null alleles are not associated with genetic
polymorphisms in the adjacent gene CYP21A2 in autism. BMC Med Genet. 2008 Jan
7;9:1.
Chaste
P, Nygren G, Anckarsäter H, Råstam M, Coleman M, Leboyer M, Gillberg C,
Betancur C. Mutation screening
of the ARX gene in patients with autism. Am J Med Genet B Neuropsychiatr Genet.
2007 Mar 5;144B(2):228-30. Mutations in the Aristaless related homeobox (ARX)
gene are associated with a broad spectrum of disorders….but they found them to
be very uncommon in autism.)
Nabi
R, Serajee FJ, Chugani DC, Zhong H, Huq AH. Association of tryptophan 2,3 dioxygenase gene
polymorphism with autism. Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):63-8.
(Haplotype analysis also demonstrated significant difference in the
transmission of TDO2 haplotypes to autistic subjects (P = 0.0027). Our results
suggest the presence of a susceptibility mutation in the TDO2 or a nearby gene,
but may also represent a chance finding.)
Asano
E, Kuivaniemi H, Huq AH, Tromp G, Behen M, Rothermel R, Herron J, Chugani DC. A study of novel polymorphisms in the upstream region
of vasoactive intestinal peptide receptor type 2 gene in autism. J Child Neurol. 2001 May;16(5):357-63 (These preliminary
results suggest that VIPR2 may have a role in gastrointestinal symptoms and
stereotypical behaviors in autism, although they admit that a much larger study
would help)
Loat
C, Curran S, Lewis C, Abrahams B, Duvall J, Geschwind D, Bolton P, Craig I. Methyl - CpG - binding protein (MECP2) polymorphisms
and vulnerability to autism. Genes
Brain Behav. 2008 Jun 2.
Allan AM, Liang X, Luo Y, Pak C, Li X, Szulwach KE, Chen D, Jin P, Zhao X. The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits. Hum Mol Genet. 2008 Jul 1;17(13):2047-57. Epub 2008 Apr 1.
Jill
James S, Melnyk S, Jernigan S, Hubanks A, Rose S, Gaylor DW. Abnormal Transmethylation/transsulfuration Metabolism
and DNA Hypomethylation Among Parents of Children with Autism. J Autism Dev Disord. 2008 May 30.
Kato
C, Tochigi M, Koishi S, Kawakubo Y, Yamamoto K, Matsumoto H, Hashimoto O, Kim
SY, Watanabe K, Kano Y, Nanba E, Kato N, Sasaki T. Association study of the commonly recognized
breakpoints in chromosome 15q11-q13 in Japanese autistic patients. Psychiatr
Genet. 2008 Jun;18(3):133-6.
Vincent
JB, Choufani S, Horike S, Stachowiak B, Li M, Dill FJ, Marshall C, Hrynchak M,
Pewsey E, Ukadike KC, Friedman JM, Srivastava AK, Scherer SW. A translocation t(6;7)(p11-p12;q22) associated with
autism and mental retardation: localization and identification of candidate
genes at the breakpoints. Psychiatr Genet. 2008 Jun;18(3):101-9.
Maussion
G, Carayol J, Lepagnol-Bestel AM, Tores F, Loe-Mie Y, Milbreta U, Rousseau F,
Fontaine K, Renaud J, Moalic JM, Philippi A, Chedotal A, Gorwood P, Ramoz N,
Hager J, Simonneau M. Convergent evidence
identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a
susceptibility gene for autism. Hum Mol Genet. 2008 May 20.
Bayou
N, M'rad R, Belhaj A, Daoud H, Ben Jemaa L, Zemni R, Briault S, Helayem MB,
Chaabouni H. De novo balanced
translocation t (7;16) (p22.1; p11.2) associated with autistic disorder. J
Biomed Biotechnol. 2008;2008:231904.
Newmeyer
A, deGrauw T, Clark J, Chuck G, Salomons G. Screening of male patients with autism spectrum
disorder for creatine transporter deficiency. Neuropediatrics. 2007 Dec;38(6):310-2.
Kent
L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR, McMahon R, Yates
JR.
X linked ichthyosis (steroid sulphatase
deficiency) is associated with increased risk of attention deficit
hyperactivity disorder, autism and social communication deficits. J Med Genet. 2008 Apr 15.
Gamerdinger
U, Eggermann T, Schubert R, Schwanitz G, Kreiss-Nachtsheim M. Rare interstitial deletion 9q31.2 to q33.1 de novo:
longitudinal study in a patient over a period of more than 20 years. Am J Med
Genet A. 2008 May 1;146A(9):1180-4.
Kim
SJ, Brune CW, Kistner EO, Christian SL, Courchesne EH, Cox NJ, Cook EH. Transmission disequilibrium testing of the chromosome
15q11-q13 region in autism. Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 24.
Wassink
TH, Vieland VJ, Sheffield VC, Bartlett CW, Goedken R, Childress D, Piven J. Posterior probability of linkage analysis of autism
dataset identifies linkage to chromosome 16. Psychiatr Genet. 2008 Apr;18(2):85-91.
Roohi
J, Montagna C, Tegay DH, Palmer LE, Devincent C, Pomeroy JC, Christian SL,
Nowak N, Hatchwell E. Disruption of
Contactin 4 in 3 Subjects with Autism Spectrum Disorder. J Med Genet. 2008 Mar
18.
Ramoz
N, Cai G, Reichert JG, Silverman JM, Buxbaum JD. An analysis of candidate autism loci on chromosome
2q24-q33: Evidence for association to the STK39 gene. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 17.
Dykens
EM, Sutcliffe JS, Levitt P. Autism and 15q11-q13 disorders: behavioral, genetic, and
pathophysiological issues. Ment Retard Dev Disabil Res Rev. 2004;10(4):284-91.
Nurmi
EL, Dowd M, Tadevosyan-Leyfer O, Haines JL, Folstein SE, Sutcliffe JS. Exploratory subsetting of autism families based on
savant skills improves evidence of genetic linkage to 15q11-q13. J Am Acad
Child Adolesc Psychiatry. 2003 Jul;42(7):856-63
Cohen
IL, Liu
X, Schutz
C, White
BN, Jenkins
EC, Brown
WT, Holden
JJ Association of autism severity
with a monoamine oxidase A functional polymorphism.Clin Genet.
2003 Sep;64(3):190-7.
Huang
YY, Cate
SP, Battistuzzi
C, Oquendo
MA, Brent
D, Mann
JJ An association between a
functional polymorphism in the monoamine oxidase a gene promoter, impulsive
traits and early abuse experiences Neuropsychopharmacology. 2004 Aug;29(8):1498-505.
Davis
LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J, Wassink TH. Cortical enlargement in autism is associated with a
functional VNTR in the monoamine oxidase A gene. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 24. (see
MRI scanning concerning brain
enlargement. A polymorphism exists within the promoter region of the MAOA gene
that influences MAOA expression levels so that "low activity" alleles
are associated with increased neurotransmitter levels in the brain. Individuals
with autism often exhibit elevated serotonin levels. A consistent association
between the "low activity" allele and larger brain volumes for
regions of the cortex in children with autism but not in controls. They did not
find evidence for over-transmission of the "low activity" allele in a
separate sample of 114 affected sib pair families.)
Roohi
J, Devincent CJ, Hatchwell E, Gadow KD. Association of a Monoamine
Oxidase-A Gene Promoter Polymorphism With ADHD and Anxiety in Boys With Autism
Spectrum Disorder. J Autism Dev Disord.
2008 Jun 20.
Hranilović
D, Novak R, Babić M, Novokmet M, Bujas-Petković Z, Jernej B. Hyperserotonemia in autism: the potential role of
5HT-related gene variants. Coll Antropol. 2008 Jan;32 Suppl
1:75-80.
(they looked at the effect of the MAOA gene and others in increasing the
serotonin levels of the platelets).
Return to Home Page and Top of Page
Buxbaum
JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J, Cook EH Jr,
Fang Y, Song CY, Vitale R. Association between
a GABRB3 polymorphism and autism. Mol
Psychiatry. 2002;7(3):311-6. (gamma-aminobutyric acid type-A receptor beta3
subunit gene (GABRB3) has been associated in one study(2) but not others.(3-5)
We completed an association analysis with 155CA-2 using the transmission disequilibrium
test (TDT) in a set of 80 autism families (59 multiplex and 21 trios). We also
used four additional markers (69CA, 155CA-1, 85CA, and A55CA-1) localized
within 150 kb of 155CA-2. The use of multi-allelic TDT (MTDT) (P < 0.002),
as well as the TDT (P < 0.004), demonstrated an association between autistic
disorder and 155CA-2 in these families. Meiotic segregation distortion could be
excluded as a possible cause for these results since no disequilibrium was
observed in unaffected siblings. These findings support a role for genetic
variants within the GABA receptor gene complex in 15q11-13 in autistic
disorder.)
McCauley JL, Olson LM, Delahanty R, Amin T, Nurmi EL, Organ EL, Jacobs MM, Folstein SE, Haines JL, Sutcliffe JS. A linkage disequilibrium map of the 1-Mb 15q12 GABA(A) receptor subunit cluster and association to autism Am J Med Genet B Neuropsychiatr Genet. 2004 Nov 15;131B(1):51-9 (looked into because of the association with the Prader-Willi/Agelmann syndrome)
Return to Home Page and Top of Page
Tuberous
sclerosis (assn)
(This is a specific uncommon
condition that is found to have an excess of autism. Its help in indicating the background to the disease in the brain
is not good. Click on the Marcotte
paper and get some more information on the illness)
Marcotte
L, Crino PB. The neurobiology of the tuberous sclerosis complex.
Neuromolecular Med. 2006;8(4):531-46.
Wiznitzer
M. Autism and tuberous sclerosis. J Child Neurol. 2004 Sep;19(9):675-9.
Review
Humphrey
A, Neville BG, Clarke A, Bolton PF. Autistic regression associated with
seizure onset in an infant with tuberous sclerosis. Dev Med Child Neurol. 2006
Jul;48(7):609-11.
Asano
E, Chugani DC, Muzik O, Behen M, Janisse J, Rothermel R, Mangner TJ,
Chakraborty PK, Chugani HT. Autism in tuberous sclerosis complex is related to both cortical and
subcortical dysfunction. Neurology. 2001 Oct 9;57(7):1269-77.
Return to Home Page and Top of Page
Phenylketonurea (assn)
Baieli
S, Pavone L, Meli C, Fiumara A, Coleman M. Autism and phenylketonurea. J Autism Dev Disord. 2003 Apr;33(2):201-4.
Smith-Lemli-Opitz syndrome:
a genetic abnormality of the
cholesterol manufacturing path (NB all normal steroid hormones like androgens and
oestrogens are made from cholesterol in the body. This is one of the groups
where the syndrome of autism is noticeably different from the wide range of ASD
as seen in other cases)
Bukelis
I, Porter FD, Zimmerman AW, Tierney E. Smith-Lemli-Opitz syndrome and
autism spectrum disorder. Am J Psychiatry. 2007 Nov;164(11):1655-61.
Sikora
DM, Pettit-Kekel K, Penfield J, Merkens LS, Steiner RD. The near universal
presence of autism spectrum disorders in children with Smith-Lemli-Opitz
syndrome. Am J Med Genet A. 2006 Jul 15;140(14):1511-8.
Return to Home Page and Top of Page
Association
with Neuroligin and Neurexin
(X-linked, and currently
being chased)
Feng
J, Schroer R, Yan J, Song W, Yang C, Bockholt A, Cook EH Jr, Skinner C,
Schwartz CE, Sommer SS. High frequency of neurexin 1beta signal peptide
structural variants in patients with autism. Neurosci Lett. 2006 Nov 27;409(1):10-3.
Tabuchi
K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Südhof TC. A
neuroligin-3 mutation implicated in autism increases inhibitory synaptic
transmission in mice. Science. 2007 Oct 5;318(5847):71-6
Levinson
JN, El-Husseini A. A crystal-clear interaction: relating
neuroligin/neurexin complex structure to function at the synapse. Neuron. 2007
Dec 20;56(6):937-9.
Yamakawa
H, Oyama S, Mitsuhashi H, Sasagawa N, Uchino S, Kohsaka S, Ishiura S.
Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are
affected by autism-related mutations. Biochem Biophys Res Commun. 2007 Mar 30;355(1):41-6.
Talebizadeh
Z, Lam DY, Theodoro MF, Bittel DC, Lushington GH, Butler MG. Novel splice
isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet.
2006 May;43(5):e21.

This
attempts to show at which point during the development we see the activity of
specific genes
during
hard line period leading up to the box with the gene’s name in it. However it
may continue past this (dotted line)
to
have a period of influence (Pardo and Eberhart 2007)
Chen X, Liu H, Shim AH, Focia PJ, He X. Structural basis for synaptic adhesion mediated by neuroligin-neurexin interactions. Nat Struct Mol Biol. 2008 Jan;15(1):50-6. Epub 2007 Dec 16.
De
Jaco A, Comoletti D, King CC, Taylor P. Trafficking of cholinesterases and neuroligins mutant
proteins An association with autism. Chem Biol Interact. 2008 Apr 29. Recent studies reported that sequence
polymorphisms in neuroligin-3 (NLGN3) and neuroligin-4 (NLGN4) genes have been
linked to autism spectrum disorders indicating neuroligin genes as candidate
targets in brain disorders. They have characterized a single mutation found in
two affected brothers that substituted Arg451 to Cys in NL3. Data show that the exposed Cys causes
retention of the protein in the endoplasmic reticulum (ER) when expressed in
HEK-293 cells. Mutations in
acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) and found a similar
processing deficiency and intracellular retention (De Jaco et al., J Biol Chem.
2006, 281:9667-76). NL3, AChE and BChE mutant proteins are recognized as
misfolded in the ER, and degraded via the proteasome pathway. A 2D electrophoresis coupled with mass
spectrometry based approach was used to analyze proteins co-immunoprecipitating
with NL3 and show differential expression of factors interacting with wild type
and mutant NL3. We identified several proteins belonging to distinct ER
resident chaperones families, including calnexin, responsible for playing a
role in the folding steps of the AChE and NLs.
The wonder is whether we are looking at changes in protein modification
within the ER.
Yan
J, Noltner K, Feng J, Li W, Schroer R, Skinner C, Zeng W, Schwartz CE, Sommer
SS.
Neurexin 1alpha structural variants
associated with autism. Neurosci Lett. 2008 Jun 27;438(3):368-70. Epub 2008 Apr 25. (Neurexins are presynaptic membrane
cell-adhesion molecules which bind to neuroligins, a family of proteins that
are associated with autism. To explore the possibility that structural variants
in the neurexin alpha genes predispose to autism, the coding regions and
associated splice junctions of the neurexin 1alpha gene were sequenced in 116
Caucasian patients with autism and 192 Caucasian controls. Five ultra-rare
structural variants including a predicted splicing mutation were found in
patients with autism and absent in 10,000 control alleles. However one ultra-rare one was found in a
control. Always the difficulty with
ultra-rare ones is that you don’t know which ones matter in the body all that
much and the one found in the control may have less significance than those in
the autistics)
Bolliger
MF, Pei J, Maxeiner S, Boucard AA, Grishin NV, Südhof TC. Unusually rapid evolution of Neuroligin-4 in mice.
Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6421-6. Epub 2008 Apr 23 (the
aim being to look for a genetic model)
Return to Home Page and Top of Page
Glutamate genetic
association (also see the
mitochondrial changes below)
Serajee
FJ, Zhong H, Nabi R, Huq AH. The metabotropic glutamate receptor 8 gene at
7q31: partial duplication and possible association with autism. J Med Genet.
2003 Apr;40(4):e42.
Jamain
S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M,
Bourgeron T; Paris Autism Research International Sibpair (PARIS) Study.
Linkage and association of the glutamate receptor 6 gene with autism. Mol
Psychiatry. 2002;7(3):302-10. (they have been finding out that certain mice with
autistic type symptoms have altered glutamate receptors and so it was worth
looking for this in the human cases)
Purcell
AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J.Postmortem brain
abnormalities of the glutamate neurotransmitter system in autism.Neurology.
2001 Nov 13;57(9):1618-28.
Correia C, Coutinho AM,
Diogo L, Grazina M, Marques C, Miguel T, Ataíde A, Almeida J, Borges L,
Oliveira C, Oliveira G, Vicente AM. Brief report: High frequency of biochemical
markers for mitochondrial dysfunction in autism: no association with the
mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord.
2006 Nov;36(8):1137-40.
Return to Home Page and Top of Page
Fragile X.
(this
is well investigated and you should look this up separately)
Farzin
F, Perry
H, Hessl
D, Loesch
D, Cohen
J, Bacalman
S, Gane
L, Tassone
F, Hagerman
P, Hagerman
R. Autism spectrum disorders and
attention-deficit/hyperactivity disorder in boys with the fragile X
permutation. J Dev
Behav Pediatr. 2006 Apr;27(2 Suppl):S137-44. (a good review)
Jinorose
U, Vasiknanonte P, Limprasert P, Brown WT, Panich V. The frequency of
fragile X syndrome among selected patients at Songklanagarind Hospital during
1991-1996, studied by cytogenetic and molecular methods. Southeast Asian J Trop
Med Public Health. 1997;28 Suppl 3:69-74.
Kelley DJ, Davidson RJ, Elliott JL, Lahvis GP, Yin JC, Bhattacharyya A. The Cyclic AMP Cascade Is Altered in the Fragile X Nervous System. PLoS ONE. 2007 Sep 26;2(9):e931. (increased cyclic AMP is produced by platelets, and other blood cells. This research was carried out to attempt to find the reason for the increase. Note that cAMP rise has been found in other forms of autism.
Gothelf
D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R, Erba HW, Ringel J,
Hayashi KM, Patnaik S, Golianu B, Kraemer HC, Thompson PM, Piven J, Reiss AL. Neuroanatomy of fragile X syndrome is associated with
aberrant behavior and the fragile X mental retardation protein (FMRP). Ann
Neurol. 2008 Jan;63(1):40-51.
Hay
DA.
Fragile X - A challenge to models of the
mind and to best clinical practice. Cortex. 2008 Jun;44(6):626-7. Epub 2007 Dec 23.
Brodkin
ES.
Social behavior phenotypes in fragile X syndrome,
autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al.
(2008). Behav Neurosci. 2008 Apr;122(2):483-9. Review.
McNaughton
CH, Moon J, Strawderman MS, Maclean KN, Evans J, Strupp BJ. Evidence for social anxiety and impaired social
cognition in a mouse model of fragile X syndrome. Behav Neurosci. 2008 Apr;122(2):293-300.
Garber
KB, Visootsak J, Warren ST. Fragile X syndrome. Eur J Hum Genet. 2008 Jun;16(6):666-72. Epub 2008 Apr 9
Gong
X, Bacchelli E, Blasi F, Toma C, Betancur C, Chaste P, Delorme R, Durand CM,
Fauchereau F, Botros HG, Leboyer M, Mouren-Simeoni MC, Nygren G, Anckarsäter H,
Rastam M, Gillberg IC, Gillberg C, Moreno-De-Luca D, Carone S, Nummela I, Rossi
M, Battaglia A, Jarvela I, Maestrini E, Bourgeron T; The International
Molecular Genetic Study of Autism Consortium (IMGSAC)http://www.well.ox.ac.uk/∼maestrin/iat.html.. Analysis of X chromosome inactivation in autism
spectrum disorders. Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 24. (this
goes into much more than the fragile X but gives a good indication as to how
they fit together)
Return to Home Page and Top of Page
Mitochondrial problems
(NB
the decreased levels of carnotine)
both genetic and apparently a dysfunction of the mitochondria that appear
normal under electron microscropy. Some
of the work indicates genetic changes in the DNA that is found in
mitochondria..but some researchers simply show the mitochondria not working
adequately, the reason for which is unclear.
The recent review seems to explain how the
mitochondrial modifications may give the changes that we see. However, this type of explanation has been
seen through many other causes of ASD.
See also see the SCL25A12
gene below.
Filipek
PA, Juranek J, Smith M, Mays LZ, Ramos ER, Bocian M, Masser-Frye D, Laulhere
TM, Modahl C, Spence MA, Gargus JJ. Mitochondrial dysfunction in autistic
patients with 15q inverted duplication. Ann Neurol. 2003 Jun;53(6):801-4.
Tsao
CY, Mendell JR. Autistic disorder in 2 children with mitochondrial
disorders. J Child Neurol. 2007 Sep;22(9):1121-3
Correia
C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, Ataíde A, Almeida J,
Borges L, Oliveira C, Oliveira G, Vicente AM. Brief report: High frequency of
biochemical markers for mitochondrial dysfunction in autism: no association
with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev
Disord. 2006 Nov;36(8):1137-40.
Poling
JS, Frye RE, Shoffner J, Zimmerman AW. Developmental regression and
mitochondrial dysfunction in a child with autism. J Child Neurol. 2006 Feb;21(2):170-2. (Suble changes in chemistry, bicarbonate
level, reduced cytochrome c in muscle biopsy.
They noticed that the serum creatin kinase level also was abnormally
elevated in 47% of 47 autistic patients not known to have mitochondrial
problems)
Ramoz
N, Reichert JG, Smith CJ, Silverman JM, Bespalova IN, Davis KL, Buxbaum JD.
Linkage and association of the mitochondrial aspartate/glutamate carrier
SLC25A12 gene with autism. Am J Psychiatry. 2004 Apr;161(4):662-9
Fillano JJ, Goldenthal MJ, Rhodes CH, Marin-Garcia
J. Mitrochondrial dysfunction in
patients with hypotonia, epilepsy autism and developmental delay: HEADD
syndrome. J Child Neurol. 2002;17:435-9. (They could see modifications under EM of the mitochondria,
enzyme alterations, and DNA deletions in mitochondria DNA).
Rossignol DA, Bradstreet JJ. Evidence of mitochondrial dysfunction in autism and implications for treatment. Biochem and Biotech 2008;4:2008-17. (Classical mitochondrial diseases occur in a subset of individuals with autism and are usually caused by genetic anomalies or mitochondrial respiratory pathway deficits. However, in many cases of autism, there is evidence of mitochondrial dysfunction (MtD) without the classic features associated with mitochondrial disease. MtD appears to be more common in autism and presents with less severe signs and symptoms. It is not associated with discernable mitochondrial pathology in muscle biopsy specimens despite objective evidence of lowered mitochondrial functioning. Exposure to environmental toxins is the likely etiology for MtD in autism. This demonstrates that although there is a very low prevalence of mitochondrial disease in autism, and hence none out of 20 were seen to have any alterations of mitochondria under EM on muscle biopsy, there were good reasons why the normal looking mitochondria of autism may actually not be working correctly. This would be expected to show decreased energy metabolism in the brain using ATP but more using phosphocreatinine, depleted glutathione levels, chronic gastrointestinal problems, seizures, hypotonia, abnormalities in fatty acid oxidation, impairment in beta-oxidation and various other obscure chemical alterations e.g. elevated lacta